Transocean expands its offshore drilling backlog in Norway with a new Shell contract and final approval of a major Equinor ...

Parents have cited the cost as one reason to pause a mandatory device program, but they also want to wait out a cultural ...

Shell agreed to take a 30% interest in the Bay du Nord project offshore Newfoundland and Labrador in Canada from Equinor . The Norwegian energy group will hold the remaining 70% interest ...

"While the LNG market can absorb the loss of Qatari supply, the adjustment will be achieved through demand destruction, lower inventories and sustained high prices rather than a material increase in ...

Abdi Nur Salah, a former senior policy aide to Minneapolis Mayor Jacob Frey, has been sentenced to 33 months in federal ...

TORONTO, Sept. 30, 2026 /CNW/ -- CABHI (Centre for Aging + Brain Health Innovation), powered by Baycrest, is marking World Alzheimer's Month by launching a new funding program to accelerate the growth ...

BRITS inundated with mysterious spam calls are being urged to stay vigilant over requests to add unknown numbers to WhatsApp. Security experts have urged Brits to turn on security settings to stay ...

iOS 27 lets users switch one number between two iPhones — but what about the UAE? Apple’s iOS 27 has introduced a new feature that could be particularly useful for people who regularly switch between ...

A Moscow firm uses shell companies and cryptocurrency to launder money, and a custom app to forge trade records, to help Russia bypass sweeping financial restrictions. By Aaron Krolik Aaron Krolik ...

If you use two iPhones, you no longer need to run separate carrier accounts for each of them, thanks to a new iOS 27 feature: iPhone Handoff. Mentioned briefly at WWDC and in more detail during ...

CALGARY/HOUSTON/LONDON, Sept 17 (Reuters) - Partners in the Shell-led (SHEL.L), opens new tab LNG Canada export project could reach a final investment decision on its Phase 2 expansion as early as ...

Novartis has extended its losing streak, stopping an amyotrophic lateral sclerosis (ALS) program after flunking a phase 2 trial. The study compared VHB937, a TREM2 stabilizer and activator, to placebo ...